Tranexamic acid and Sugammadex drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tranexamic acid (tranexamic acid) and Sugammadex (sugammadex). Common drug interactions include arthralgia among females and bradypnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Tranexamic acid and Sugammadex. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.
What is Tranexamic acid?
Tranexamic acid has active ingredients of tranexamic acid. It is often used in heavy or prolong menstrual bleeding. eHealthMe is studying from 8,687 Tranexamic acid users. Check the latest studies of Tranexamic acid.
What is Sugammadex?
Sugammadex has active ingredients of sugammadex. eHealthMe is studying from 255 Sugammadex users. Check the latest studies of Sugammadex.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
41 people who take Tranexamic acid and Sugammadex together, and have interactions are studied.

What are the common drug interactions of Tranexamic Acid and Sugammadex, by gender? *:
female:
- Arthralgia (joint pain)
- Bone pain
- C-reactive protein increased
- Cancer pain
- Diarrhoea
- Mucosal inflammation (infection of mucous membrane)
- Oedema peripheral (superficial swelling)
- Vomiting
- Wound
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
male:
- Bradypnoea (an abnormally slow respiratory rate)
- Drug ineffective
- Hypercapnia (too much smoke)
- Hypotension (abnormally low blood pressure)
- Mydriasis (a dilation of the pupil)
- Obstructive airways disorder (a progressive disease that makes it hard to breathe)
- Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
What are the common drug interactions of Tranexamic Acid and Sugammadex, by age (0-1 to 60+)? *:
0-1:
- Drug ineffective
2-9:
- Bradypnoea (an abnormally slow respiratory rate)
- Hypercapnia (too much smoke)
- Hypotension (abnormally low blood pressure)
- Mydriasis (a dilation of the pupil)
- Obstructive airways disorder (a progressive disease that makes it hard to breathe)
- Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
10-19:
n/a
20-29:
- Skin discolouration (change of skin colour)
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
- Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
- Wound
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Disease progression
- Pain in extremity
- Oedema (fluid collection in tissue)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
What are the existing conditions these people have? *
- Dry Skin: 25 people, 60.98%
- Wound: 22 people, 53.66%
- Urinary Tract Infection: 22 people, 53.66%
- Breast Cancer Metastatic: 22 people, 53.66%
- Cellulitis (infection under the skin): 22 people, 53.66%
- Fever: 22 people, 53.66%
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 22 people, 53.66%
- Abdominal Hernia Obstructive (abdominal hernia causing a blockage): 22 people, 53.66%
- Joint Pain: 22 people, 53.66%
- Oedema Peripheral (superficial swelling): 22 people, 53.66%
* Approximation only. Some reports may have incomplete information.
Do you take Tranexamic acid and Sugammadex?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Tranexamic acid (8,687 reports)
- Sugammadex (255 reports)
Browse all drug interactions of Tranexamic acid and Sugammadex:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tranexamic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sugammadex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tranexamic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sugammadex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on tranexamic acid and sugammadex (the active ingredients of Tranexamic acid and Sugammadex, respectively), and Tranexamic acid and Sugammadex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zolpidem cause Intestinal Mass? - 5 seconds ago
- Could Zolpidem cause Complications Of Maternal Exposure To Therapeutic Drugs? - 7 seconds ago
- Could Duspatalin cause Anaemia? - 10 seconds ago
- Lacunar Infarction and Thrombocytopenia - 10 seconds ago
- Drug interactions of Temazepam and Lorazepam - 11 seconds ago
- Could Rozerem cause Jaundice - Yellow Skin? - 11 seconds ago
- Could Indomethacin cause Faecal Incontinence? - 18 seconds ago
- Could Indomethacin cause Dilatation Ventricular? - 21 seconds ago
- Could Verzenio cause Breast Cancer Metastatic? - 27 seconds ago
- Could Levothyroxine Sodium cause Ischaemic Hepatitis? - 28 seconds ago